Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
American Ginseng for Cancer-Related Fatigue
NCT00719563Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Oct 2008
- Primary completion
- Aug 2011
- Modality
- BDS (Botanical Dietary Supplement)
- Countries
- 1
01
Overview
A Phase 3 trial of panax quinquefolius in cancer-related fatigue (CRF), sponsored by Cancer and Leukemia Group B. Started Oct 2008; status: completed.
02
Drugs
panax quinquefolius
03
Conditions
cancer-related fatigue (CRF)
Beyond the preview
Go deeper on NCT00719563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719563.